{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T22:54:47Z","timestamp":1759964087797},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2014,5,8]],"date-time":"2014-05-08T00:00:00Z","timestamp":1399507200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CNS Drugs"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1007\/s40263-014-0170-6","type":"journal-article","created":{"date-parts":[[2014,5,7]],"date-time":"2014-05-07T15:56:24Z","timestamp":1399478184000},"page":"513-518","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Changes in Gait Variability with Anti-dementia Drugs: A Systematic Review and Meta-analysis"],"prefix":"10.1007","volume":"28","author":[{"given":"O.","family":"Beauchet","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. P.","family":"Launay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Allali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Annweiler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,5,8]]},"reference":[{"key":"170_CR1","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1111\/j.1532-5415.2012.04180.x","volume":"60","author":"M Montero-Odasso","year":"2012","unstructured":"Montero-Odasso M, Verghese J, Beauchet O, Hausdorff JM. Gait and cognition: a complementary approach to understanding brain function and the risk of falling. J Am Geriatr Soc. 2012;60:2127\u201336.","journal-title":"J Am Geriatr Soc"},{"key":"170_CR2","doi-asserted-by":"crossref","first-page":"155","DOI":"10.2147\/NDT.S2070","volume":"4","author":"O Beauchet","year":"2008","unstructured":"Beauchet O, Allali G, Berrut G, Hommet C, Dubost V, Assal F. Gait analysis in demented subjects: interests and perspectives. Neuropsychiatr Dis Treat. 2008;4:155\u201360.","journal-title":"Neuropsychiatr Dis Treat"},{"key":"170_CR3","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1111\/j.1532-5415.2005.53552.x","volume":"53","author":"LM Allan","year":"2005","unstructured":"Allan LM, Ballard CG, Burn DJ, Kenny RA. Prevalence and severity of gait disorders in Alzheimer\u2019s and non-Alzheimer\u2019s dementias. J Am Geriatr Soc. 2005;53:1681\u20137.","journal-title":"J Am Geriatr Soc"},{"key":"170_CR4","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1159\/000235905","volume":"55","author":"O Beauchet","year":"2009","unstructured":"Beauchet O, Allali G, Annweiler C, Bridenbaugh S, Assal F, Kressig RW, Herrmann FR. Gait variability among healthy adults: low and high stride-to-stride variability are both a reflection of gait stability. Gerontology. 2009;55:702\u20136.","journal-title":"Gerontology"},{"key":"170_CR5","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.gaitpost.2006.12.011","volume":"26","author":"G Allali","year":"2007","unstructured":"Allali G, Kressig RW, Assal F, Herrmann FR, Dubost V, Beauchet O. Changes in gait while backward counting in demented older adults with frontal lobe dysfunction. Gait Posture. 2007;26:572\u20136.","journal-title":"Gait Posture"},{"key":"170_CR6","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s12603-012-0394-4","volume":"17","author":"O Beauchet","year":"2013","unstructured":"Beauchet O, Allali G, Launay C, Herrmann FR, Annweiler C. Gait variability at fast-pace walking speed: a biomarker of mild cognitive impairment? J Nutr Health Aging. 2013;17:235\u20139.","journal-title":"J Nutr Health Aging"},{"key":"170_CR7","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1053\/apmr.2001.24893","volume":"82","author":"JM Hausdorff","year":"2001","unstructured":"Hausdorff JM, Rios DA, Eldelberg HK. Gait variability and fall risk in community-living older adults: a 1-year prospective study. Arch Phys Med Rehabil. 2001;82:1050\u20136.","journal-title":"Arch Phys Med Rehabil"},{"key":"170_CR8","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1532-5415.1997.tb00946.x","volume":"45","author":"BE Maki","year":"1997","unstructured":"Maki BE. Gait changes in older adults: predictors of falls or indicators of fear? J Am Geriatr Soc. 1997;45:313\u201320.","journal-title":"J Am Geriatr Soc"},{"key":"170_CR9","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1111\/j.1532-5415.2008.01657.x","volume":"56","author":"F Assal","year":"2008","unstructured":"Assal F, Allali G, Kressig RW, Herrmann FR, Beauchet O. Galantamine improves gait performance in patients with Alzheimer\u2019s disease. J Am Geriatr Soc. 2008;56:946\u20137.","journal-title":"J Am Geriatr Soc"},{"key":"170_CR10","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1532-5415.2009.02085.x","volume":"57","author":"M Montero-Odasso","year":"2009","unstructured":"Montero-Odasso M, Wells J, Borrie M. Can cognitive enhancers reduce the risk of falls in people with dementia? An open-label study with controls. J Am Geriatr Soc. 2009;57:359\u201360.","journal-title":"J Am Geriatr Soc"},{"key":"170_CR11","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1111\/j.1532-5415.2011.03648.x","volume":"59","author":"O Beauchet","year":"2011","unstructured":"Beauchet O, Allali G, Launay C, Fantino B, Annweiler C. Does memantine improve the gait of individuals with Alzheimer\u2019s disease? J Am Geriatr Soc. 2011;59:2181\u20132.","journal-title":"J Am Geriatr Soc"},{"key":"170_CR12","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/1471-2377-13-184","volume":"13","author":"O Beauchet","year":"2013","unstructured":"Beauchet O, Launay C, Allali G, Watfa G, Gallouj K, Herrmann F, Annweiler C. Anti-dementia drugs and changes in gait: a pre-post quasi-experimental pilot study. BMC Neurol. 2013;13:184.","journal-title":"BMC Neurol"},{"key":"170_CR13","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1471-2377-9-42","volume":"9","author":"M Montero-Odasso","year":"2009","unstructured":"Montero-Odasso M, Wells JL, Borrie MJ, Speechley M. Can cognitive enhancers reduce the risk of falls in older people with mild cognitive impairment? A protocol for a randomised controlled double blind trial. BMC Neurol. 2009;9:42.","journal-title":"BMC Neurol"},{"key":"170_CR14","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","volume":"61","author":"E Elm von","year":"2008","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol. 2008;61:344\u20139.","journal-title":"J Clin Epidemiol"},{"key":"170_CR15","doi-asserted-by":"crossref","first-page":"e1000251","DOI":"10.1371\/journal.pmed.1000251","volume":"7","author":"KF Schulz","year":"2010","unstructured":"Schulz KF, Altman DG, Moher D. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. PLoS Med. 2010;7:e1000251.","journal-title":"PLoS Med"},{"key":"170_CR16","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","volume":"12","author":"MF Folstein","year":"1975","unstructured":"Folstein MF, Folstein SE, McHugh PR. \u201cMini-mental state\u201d. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189\u201398.","journal-title":"J Psychiatr Res"},{"key":"170_CR17","doi-asserted-by":"crossref","DOI":"10.4135\/9781412984980","volume-title":"Meta-analysis: quantitative methods for research synthesis","author":"FM Wolf","year":"1986","unstructured":"Wolf FM. Meta-analysis: quantitative methods for research synthesis. Beverly Hills: Sage; 1986."},{"key":"170_CR18","doi-asserted-by":"crossref","first-page":"881","DOI":"10.2165\/11201020-000000000-00000","volume":"23","author":"K McKeage","year":"2009","unstructured":"McKeage K. Memantine: a review of its use in moderate to severe Alzheimer\u2019s disease. CNS Drugs. 2009;23:881\u201397.","journal-title":"CNS Drugs"},{"key":"170_CR19","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1586\/ern.09.23","volume":"9","author":"N Tsuno","year":"2009","unstructured":"Tsuno N. Donepezil in the treatment of patients with Alzheimer\u2019s disease. Expert Rev Neurother. 2009;9:591\u20138.","journal-title":"Expert Rev Neurother"},{"key":"170_CR20","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2147\/ciia.2007.2.1.17","volume":"2","author":"ML Onor","year":"2007","unstructured":"Onor ML, Trevisiol M, Aguglia E. Rivastigmine in the treatment of Alzheimer\u2019s disease: an update. Clin Interv Aging. 2007;2:17\u201332.","journal-title":"Clin Interv Aging"},{"key":"170_CR21","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1002\/mds.21603","volume":"22","author":"QJ Almeida","year":"2007","unstructured":"Almeida QJ, Frank JS, Roy EA, Patla AE, Jog MS. Dopaminergic modulation of timing control and variability in the gait of Parkinson\u2019s disease. Mov Disord. 2007;22:1735\u201342.","journal-title":"Mov Disord"},{"key":"170_CR22","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.neuropharm.2007.07.013","volume":"53","author":"CG Parsons","year":"2007","unstructured":"Parsons CG, St\u00f6ffler A, Danysz W. Memantine: a NMDA receptor antagonist that improves memory by restoration of homeostasis in the glutamatergic system\u2013too little activation is bad, too much is even worse. Neuropharmacology. 2007;53:699\u2013723.","journal-title":"Neuropharmacology"}],"container-title":["CNS Drugs"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-014-0170-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40263-014-0170-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-014-0170-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T19:41:21Z","timestamp":1559504481000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40263-014-0170-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5,8]]},"references-count":22,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["170"],"URL":"https:\/\/doi.org\/10.1007\/s40263-014-0170-6","relation":{},"ISSN":["1172-7047","1179-1934"],"issn-type":[{"value":"1172-7047","type":"print"},{"value":"1179-1934","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,8]]}}}